Advancing orphan drug development for rare diseases

被引：0
|
作者：
Ko, Jung Min [1 ,2 ]
机构：
[1] Seoul Natl Univ, Coll Med, Dept Pediat, Div Clin Genet, 103 Daehak Ro, Seoul 03080, South Korea
[2] Seoul Natl Univ Hosp, Rare Dis Ctr, Seoul, South Korea
来源：
CLINICAL AND EXPERIMENTAL PEDIATRICS | 2024年 / 67卷 / 07期
关键词：
D O I：
10.3345/cep.2023.01109
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：356 / 357
页数：2
相关论文
共 50 条
  • [31] Rare Genetic Diseases with Defects in DNA Repair: Opportunities and Challenges in Orphan Drug Development for Targeted Cancer Therapy
    Bhattacharjee, Sonali
    Nandi, Saikat
    CANCERS, 2018, 10 (09)
  • [32] Drug repositioning for orphan diseases
    Sardana, Divya
    Zhu, Cheng
    Zhang, Minlu
    Gudivada, Ranga C.
    Yang, Lun
    Jegga, Anil G.
    BRIEFINGS IN BIOINFORMATICS, 2011, 12 (04) : 346 - 356
  • [33] Orphan Drugs and Rare Diseases: Unveiling Biological Patterns through Drug Repurposing
    Otero-Carrasco, Belen
    Romero-Brufau, Santiago
    Alvarez-Perez, Andrea
    Ayuso-Munoz, Adrian
    Prieto-Samamaria, Lucia
    Caraca-Valente Hernandez, Juan Pedro
    Rodriguez-Gonzalez, Alejandro
    2023 IEEE 36TH INTERNATIONAL SYMPOSIUM ON COMPUTER-BASED MEDICAL SYSTEMS, CBMS, 2023, : 185 - 191
  • [34] A Global Approach to Rare Diseases Research and Orphan Products Development: The International Rare Diseases Research Consortium (IRDiRC)
    Cutillo, Christine M.
    Austin, Christopher P.
    Groft, Stephen C.
    RARE DISEASES EPIDEMIOLOGY: UPDATE AND OVERVIEW, 2ND EDITION, 2017, 1031 : 349 - 369
  • [35] Rare and orphan diseases - a national priority
    Bergeron, A
    Nunes, H
    Marchand, E
    REVUE DES MALADIES RESPIRATOIRES, 2005, 22 (06) : 919 - 921
  • [36] A RARE meeting dedicated to orphan diseases
    Petit, Helene
    BIOFUTUR, 2011, (327) : 10 - 10
  • [37] The concept of rare or orphan diseases in epilepsy
    Baulac, M.
    EPILEPSIA, 2006, 47 : 238 - 238
  • [38] Living in the light of rare and orphan diseases
    Gershkowitz, Levi G.
    MOLECULAR GENETICS AND METABOLISM, 2014, 111 (02) : S45 - S46
  • [39] Orphan drugs and rare diseases in Andorra
    Gea, E.
    Gil, E.
    Barral, N.
    Gonzalez, V.
    Soler, A.
    Avellanet, M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 963 - 963
  • [40] ORPHAN AND RARE DISEASES - THE PAYER PERSPECTIVE
    Spoors, J.
    Rietveld, A.
    VALUE IN HEALTH, 2014, 17 (07) : A542 - A542
12345